Merck Arcoxia At ACR: Data Suggest Thrombotic Profile Similar To Vioxx

Merck's Arcoxia (etoricoxib) does not interfere with the platelet aggregation effects of low-dose aspirin, according to an abstract presented at the American College of Rheumatology annual scientific meeting Nov. 11-15 in San Francisco